Sir, Mid-term outcomes of penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK)
we have revisited our keratoconic cohort and retrospectively collected refraction and best (spectacle)-corrected visual acuities (BCVAs) at 2 and 4 years post-PK or post-DALK plus the incidence of rejection and graft failure. Data analyses were undertaken via independent t-tests or the Mann-Whitney test.
At 2 years, there were visual acuity data for 17 eyes with PK and 10 with DALK, and refractive data for 16 eyes with PK and 12 with DALK; at four years, there were visual acuity data for 17 eyes with PK and 9 with DALK, and refractive data for 14 eyes with PK and 9 with DALK ( Table 1 ). The refractive outcomes were similar except that the DALK group had significantly less astigmatism at 2 years compared with those that had undergone PK. A BCVA of 6/6 or better was achieved 4 years postoperatively by more than three-quarters of the PK group, but only a third of the DALK group ( Figure 1 ). Two of the PK patients (10%) underwent a second PK: one had secondary graft failure following infective keratitis at 9 months and another developed large, fluctuating astigmatism following suture removal at 32 months. None of the DALKs required repeat corneal transplantation. Both groups had graft rejection episodes; three in the PK group had endothelial rejections and two in the DALK group suffered epithelial or stromal rejection, all of which resolved with the appropriate treatment.
This report confirms both PK and DALK as successful surgical options for keratoconus. A constant significant finding was the attainment of better visual acuity via PK than following DALK with improvement in both sets over time (Figure 1 ). The two groupings experienced similar rates of graft rejection episodes, yet none of the DALKs required regrafting; these outcomes are similar to earlier studies.
2,4 Furthermore, we too observed that the DALK patients had a shorter post-op rehabilitation period than PK patients. 3, 5 Consequently, we propose that DALK offers faster rehabilitation plus an improved chance of long-term graft survival, but at the expense of reduced BCVA compared with PK. 
